Conference Call Scheduled for Tuesday, August 13, 2019 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
PORTLAND, Maine, May 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ETPORTLAND, Maine, May 07, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
PORTLAND, Maine, March 29, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
PORTLAND, Maine, March 27, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
PORTLAND, Maine, March 26, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
PORTLAND, Maine, Feb. 28, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
PORTLAND, Maine, Feb. 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018
Conference Call Scheduled for Thursday, February 14, 2019 at 9:00 AM ET PORTLAND, Maine, Feb. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces USDA Approval of Dual-Force™ First Defense®
PORTLAND, Maine, Dec. 11, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...